期刊文献+

强化他汀治疗在急性冠脉综合征患者PCI术后中的应用效果观察 被引量:1

Application efficacy observation of statin intensive treatment in acute coronary syndrome patients after PCI surgery
下载PDF
导出
摘要 目的探讨急性冠脉综合征患者PCI术后应用强化他汀治疗的临床效果.方法选取本院2012年11月~2013年11月收治的88例急性冠脉综合征PCI术治疗的患者为研究对象,将其随机分成A组与B组,A组40例患者给予常规治疗,B组48例患者给予强化他汀治疗,观察两组患者的治疗效果.结果两组患者治疗后的胆固醇(TC)、低密度脂蛋白(LDL-C)、超敏C反应蛋白(hs-CRP)均较治疗前有所下降,B组下降更为明显,差异有统计学意义(P<0.05);治疗后两组患者的血浆丙氨酸氨基转移酶(ALT)、肌酐(Cr)均有所升高,但两组比较差异无统计学意义;A组患者心绞痛复发率为27.1%,心力衰竭发生率为18.7%,B组患者心绞痛复发率为15.0%,心力衰竭发生率为10.0%,B组患者的复发率及心力衰竭发生率明显低于A组,差异有统计学意义(P<0.05).结论急性冠脉综合征患者PCI术后应用大量他汀类药物进行强化治疗的临床效果较为显著,能显著改善患者的预后,值得在临床推广应用. Objective To explore the clinical efficacy of applying statin intensive treatment to acute coronary syndrome (ACS) patients after PCI surgery. Methods Eighty-eight ACS patients who underwent PCI surgery admitted into our hospital from November 2012 to November 2013 were selected as research objects and randomly divided into group A and group B.In the group A (n=40),patients were treated by regular therapy,while in the group B (n=48),statin intensive treatment was provided.The efficacy in both groups were observed. Results After treatment,the total cholesterol (TC),low density lipoprotein cholesterol (LDL-C),and hypersensitive C reactive protein (hs-CRP) to some extent decreased in comparison with those before treatment in both groups.The decrease in the group B was more obvious with statistical differences (P〈0.05).The alanine transaminase (ALT) and creatinine (Cr) after treatment both increased,but didn't dis- play a significant difference between the two groups.The recurrent rate of angina pectoris and incidence of cardiac fail- ure in the group A were 27.1% and 18.7%,while in the group B,they were 15.0% and 10.0% in turn,which were much lower than those in the group A and displayed statistical differences (P〈0.05). Conclusion Application of substantial amount of statins for intensive treatment in ACS patients after PCI surgery can obtain remarkable clinical effect and improve patient's prognosis,which is worthy of expansion in clinic.
作者 邱海龙
出处 《中国当代医药》 2014年第11期77-79,共3页 China Modern Medicine
关键词 急性冠脉综合征 PCI术 强化治疗 他汀类药物 Acute coronary syndrome PCI surgery Intensive treatment Statin
  • 相关文献

参考文献13

二级参考文献37

  • 1林永忠,孙长凯,肖昭扬,宋桂荣,尹琳,包礼平.不同疗程阿托伐他汀对脑梗死患者血脂和神经功能缺损程度的影响[J].中国临床康复,2006,10(20):28-31. 被引量:20
  • 2王平,宋执敬,宋军,李勇,荆媛,任绪功.阿托伐他汀在急性冠脉综合征血脂正常患者中的早期应用[J].心血管康复医学杂志,2006,15(4):362-365. 被引量:7
  • 3Cannon CP,Braunwald E,Mccabe CH,et al.Pravastatin or atorvastatin evaluation and infection theraphy-thrombolysis in myocardial infarction 22 investigators.Intensive versus moderate lipid lowering with statins after acute coronary syndromes.N Engl J Med,2004,350:1495-1504.
  • 4de Lemos JA,Blazing MA,Wiviott SD,et al.Early intensive vs delayed conservative simvastatin strategy in patients with acute coronary syndrome.Phase Z of the A to Z trial.JAMA,2004,292:1307-1316.
  • 5Pedersen TR,Facrgeman O,John JP,et al.High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction.The IDEAL Study:a randomized controlled trial.JAMA,2005,294:2437-2445.
  • 6Cannon CP,Steinberg BA,Murphy SA,et al.Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy.J Am Coll Cardiol,2006,48:438-445.
  • 7Faergeman O.High-dose atorvastatin or normal-dose simvastatin in treatment of patients with coronary heart disease (IDEAL trial)-secondary publication.Ugesker Laeger,2006,168:1769-1771.
  • 8Arntz HR,Agrawal R,Wunderlich W,et al.Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event:the randomized Lipid-Coronary Artery Disease(L-CAD) Study JAMA.Am J Cardiol,2000,86:1293-1300.
  • 9Serruys PW,de Feyter P,Macaya C,et al.Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention.JAMA,2002,287:3215-3222.
  • 10Briguori C.NAPLES Ⅱ.Novel Approaches for Preventing or Limiting Event Study:impact of single high loading dose of atorvastatin on periprocedral myocardial infarction.J Am Coll Cardiol,2009,54:2157.

共引文献23

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部